CI Investments Inc’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.9M | Sell |
123,910
-89,801
| -42% | -$19.9M | 0.13% | 148 |
|
|
2025
Q4 | $48.8M | Buy |
213,711
+35,832
| +20% | +$8.16M | 0.21% | 102 |
|
|
2025
Q3 | $41.2M | Sell |
177,879
-24,811
| -12% | -$5.05M | 0.15% | 118 |
|
|
2025
Q2 | $37.6M | Buy |
202,690
+9,736
| +5% | +$1.81M | 0.14% | 131 |
|
|
2025
Q1 | $40.4M | Buy |
192,954
+39,490
| +26% | +$7.68M | 0.17% | 112 |
|
|
2024
Q4 | $27.3M | Sell |
153,464
-35,033
| -19% | -$6.44M | 0.1% | 147 |
|
|
2024
Q3 | $37.2M | Sell |
188,497
-2,292
| -1% | -$428K | 0.14% | 131 |
|
|
2024
Q2 | $32.7M | Sell |
190,789
-23,741
| -11% | -$3.93M | 0.13% | 131 |
|
|
2024
Q1 | $39.1M | Buy |
214,530
+27,953
| +15% | +$4.82M | 0.16% | 122 |
|
|
2023
Q4 | $28.9M | Buy |
186,577
+55,110
| +42% | +$8.03M | 0.15% | 131 |
|
|
2023
Q3 | $19.6M | Sell |
131,467
-9,944
| -7% | -$1.46M | 0.11% | 160 |
|
|
2023
Q2 | $19.1M | Buy |
141,411
+10,913
| +8% | +$1.6M | 0.1% | 174 |
|
|
2023
Q1 | $20.8M | Sell |
130,498
-53,203
| -29% | -$8.13M | 0.1% | 168 |
|
|
2022
Q4 | $29.7M | Buy |
183,701
+4,282
| +2% | +$657K | 0.15% | 131 |
|
|
2022
Q3 | $24.1M | Buy |
179,419
+2,389
| +1% | +$343K | 0.12% | 148 |
|
|
2022
Q2 | $27.1M | Sell |
177,030
-546,862
| -76% | -$83.6M | 0.13% | 155 |
|
|
2022
Q1 | $117M | Buy |
723,892
+175,383
| +32% | +$25.5M | 0.43% | 63 |
|
|
2021
Q4 | $74.3M | Buy |
548,509
+149,960
| +38% | +$17.7M | 0.26% | 105 |
|
|
2021
Q3 | $43M | Buy |
398,549
+355,467
| +825% | +$40.6M | 0.16% | 142 |
|
|
2021
Q2 | $4.85M | Sell |
43,082
-17,645
| -29% | -$1.99M | 0.02% | 354 |
|
|
2021
Q1 | $6.57M | Sell |
60,727
-12,708
| -17% | -$1.36M | 0.03% | 291 |
|
|
2020
Q4 | $7.87M | Sell |
73,435
-24,849
| -25% | -$2.39M | 0.03% | 273 |
|
|
2020
Q3 | $8.61M | Buy |
98,284
+7,762
| +9% | +$731K | 0.04% | 235 |
|
|
2020
Q2 | $8.89M | Sell |
90,522
-4,044
| -4% | -$356K | 0.05% | 226 |
|
|
2020
Q1 | $7.21M | Sell |
94,566
-3,796
| -4% | -$323K | 0.04% | 205 |
|
|
2019
Q4 | $8.71M | Sell |
98,362
-8,319
| -8% | -$691K | 0.04% | 232 |
|
|
2019
Q3 | $8.08M | Buy |
+106,681
| New | +$7.31M | 0.04% | 225 |
|
|
2017
Q1 | – | Sell |
-36,578
| Closed | -$2.29M | – | 193 |
|
|
2016
Q4 | $2.29M | Sell |
36,578
-417,386
| -92% | -$25.5M | 0.03% | 166 |
|
|
2016
Q3 | $28.6M | Buy |
453,964
+120,832
| +36% | +$7.82M | 0.31% | 88 |
|
|
2016
Q2 | $20.6M | Sell |
333,132
-333,100
| -50% | -$20.3M | 0.23% | 95 |
|
|
2016
Q1 | $38.1M | Sell |
666,232
-157,000
| -19% | -$8.75M | 0.49% | 60 |
|
|
2015
Q4 | $48.8M | Buy |
823,232
+100,000
| +14% | +$5.76M | 0.62% | 52 |
|
|
2015
Q3 | $39.4M | Sell |
723,232
-102,935
| -12% | -$6.7M | 0.51% | 55 |
|
|
2015
Q2 | $55.5M | Buy |
826,167
+170,167
| +26% | +$11.1M | 0.61% | 52 |
|
|
2015
Q1 | $38.4M | Sell |
656,000
-1,018,000
| -61% | -$61.5M | 0.4% | 63 |
|
|
2014
Q4 | $110M | Sell |
1,674,000
-1,500,000
| -47% | -$94.6M | 1.24% | 22 |
|
|
2014
Q3 | $183M | Buy |
3,174,000
+1,449,000
| +84% | +$80.4M | 1.91% | 9 |
|
|
2014
Q2 | $97.4M | Sell |
1,725,000
-2,510,500
| -59% | -$132M | 0.96% | 31 |
|
|
2014
Q1 | $218M | Sell |
4,235,500
-464,100
| -10% | -$23.5M | 2.3% | 6 |
|
|
2013
Q4 | $248M | Sell |
4,699,600
-1,620,400
| -26% | -$79.6M | 2.72% | 6 |
|
|
2013
Q3 | $283M | Sell |
6,320,000
-180,000
| -3% | -$7.98M | 3.18% | 5 |
|
|
2013
Q2 | $269M | Buy |
+6,500,000
| New | +$284M | 2.92% | 7 |
|
Other funds holding ABBV
VCM
VPM
CI Investments Inc's ABBV Position: Q1 2026 in Review
CI Investments Inc reduced its AbbVie (ABBV) stake by 42% in Q1 2026, selling an estimated $19.9M and leaving 123,910 shares worth $26.9M. The position accounts for 0.13% of the portfolio, ranked #148.
CI Investments Inc first reported a position in ABBV in Q2 2013 and has held it in 42 quarters since. The position peaked at $283M in Q3 2013. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- CI Investments Inc held 123,910 shares of AbbVie worth $26.9M as of Q1 2026.
- CI Investments Inc sold 89,801 AbbVie shares in Q1 2026, an estimated $19.9M.
- AbbVie made up 0.13% of CI Investments Inc's portfolio in Q1 2026, its #148 holding.
- CI Investments Inc first reported a position in AbbVie in Q2 2013 and has held it in 42 quarters since.
- CI Investments Inc's AbbVie position peaked at $283M in Q3 2013.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on CI Investments Inc's 13F filing for Q1 2026, filed 13 May 2026.